Global Medical Radioisotopes Market Size Likely to Surpass at a CAGR of 6.34% By 2034

Medical Radioisotopes Market Size

Global Medical Radioisotopes Market size was valued at USD 803 Million in 2025 and is expected to reach USD 1382 Million by 2034, at a CAGR of 6.34% during the forecast period 2025 – 2034.

Medical Radioisotopes Market Overview

Giant demand for the global medical radioisotopes market: a few key insights. Introducing Therefore, the growth of the global medical radioisotopes market is expected to be forceful with growing applications in diagnostics and therapeutics. Increasing incidence of chronic diseases like cancer and cardiovascular disorders is increasing the demand for the medical radioisotopes, especially in nuclear medicine.

These isotopes are vital for imaging modalities such as PET and SPECT, facilitating the early diagnosis and appropriate management of diseases. Tc-99m is one of the most used isotopes, with this isotope representing over 80% of all nuclear medicine procedures worldwide.

Market driving factors include the expansion of nuclear medicine infrastructure, increasing government investments, and advancements in technology for isotope production. The United States, Canada, and Germany are countries with powerful nuclear medicine institutions guaranteeing radioisotope supply for diagnosis and therapy.

The increasing demand for personalized medicine is creating new opportunities for medical radioisotopes, especially theragnostic applications that combine diagnosis and therapy. Lutetium-177 (Lu-177) recently transitioned into a revolutionary isotope for prostate and neuroendocrine tumor-targeted radiopharmaceutical therapy.

New developments in isotope production technologies are also changing the face of the industry. An example includes cyclotron-based production, which is proving to be a practical solution for the sustainable supply of medical isotopes and an alternative to reactor-based methods.

One company leading the charge is ARTMS, a Canadian firm that has created a cyclotron-based method for generating Tc-99m and now allows for a reduction in reliance on aging nuclear reactors while also providing a sustainable solution to supply chain concerns.

In Europe, research institutes are investigating the use of cyclotrons for Actinium-225 production, which shows promise in targeted alpha therapy for treating cancer. A tsunami of new radiopharmaceutical treatments is coming to the clinics during the forecast period.

North America dominated the global market owing to high healthcare expenditure, huge research activities, and the presence of top players such as Lantheus Holdings, Cardinal Health, and NorthStar Medical Radioisotopes. Key players in the market are additionally benefitting from government initiatives intended to increase the local production of radioisotopes.

As an example, in 2023 the U.S. Department of Energy (DOE) announced a $30 million grant to strengthen the domestic medical radioisotope supply chain and decrease reliance on external sources. In parallel, European countries are investing in cyclotron-based production technology to reduce supply chain risks related to aging nuclear reactors.

Asia-Pacific is expected to be the fastest-growing market owing to rising adoption of nuclear medicine, increasing healthcare expenditure, and growing awareness towards the benefits of early detection of disease through advanced imaging systems. With the expansion of nuclear medicine in China, Japan, and India, the cases are growing in this region, and countries are studying them in detail.

The competitive landscape of the medical radioisotopes market is also impacted by strategic collaborations and product launchings. However, key producers are themselves joining hands to increase their production capacities and reach. In 2023, Cardinal Health joined TerraPower Isotopes to begin large-scale production of Actinium-225 to support theranostics needs out of its Center for Theranostics Advancement in Indianapolis.

Report Scope

CMI has comprehensively analyzed the Comprehensive Metabolic Panel Testing Market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict the in-depth scenario of the market. Segment-wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Cystatin C Assay industry.

The competitive landscape includes key innovators, after-market service providers, and market giants, as well as niche players, who are studied and analyzed extensively for their strengths, weaknesses as well as value-addition prospects. In addition, this report covers key player profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends, and dynamics in partnerships.

List of the prominent players in the Medical Radioisotopes Market:

• Abbott Laboratories
• Advanced Accelerator Applications (AAA)
• Lantheus Holdings
• Siemens Healthineers
• Eli Lilly
• Sanofi
• Orano
• Rosatom
• Mediso
• Advanced Cyclotron Systems
• GE Healthcare
• Cardinal Health
• Curium
• IBA Radiopharma Solutions
• NorthStar Medical Radioisotopes
• BWX Technologies
• Shine Medical Technologies
• NTP Radioisotopes
• Isotopia Molecular Imaging
• Eckert & Ziegler
• Telix Pharmaceuticals
• Others

The Medical Radioisotopes Market is segmented as follows:

By Type

• Tc-99m
• Cobalt-60
• Iodine Radioisotopes

By Application

• Nuclear Therapy
• Equipment Radioactive Source
• Diagnosis
• Others

By Type

• Tc-99m
• Cobalt-60
• Iodine Radioisotopes

By Application

• Nuclear Therapy
• Equipment Radioactive Source
• Diagnosis
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America